The KAVI-Institute of Clinical Research (KAVI-ICR) at the University of Nairobi is advancing global vaccine science as a key partner in the upcoming Phase II clinical trial of a cholera conjugate vaccine. This trial aims to provide stronger, longer-lasting protection against cholera, particularly for children under five years, who face the highest risk.

Nairobi Investigators’ Meeting